172 related articles for article (PubMed ID: 8020736)
1. [Is it advisable to produce anti-Rh0(D) immunoglobulin for the prevention of hemolytic disease of the newborn? (apropos the article by A. A. Mikhaĭlova and N. Ia. Klimova)].
Olovnikova NI; Chertkov IL
Gematol Transfuziol; 1993 Mar; 38(3):38-40. PubMed ID: 8020736
[No Abstract] [Full Text] [Related]
2. [The expediency of producing antirhesus-Rh0(D) immunoglobulin and its use for preventing hemolytic disease of the newborn (for discussion)].
Mikhaĭlova AA; Klimova NIa
Gematol Transfuziol; 1992; 37(7-8):39-40. PubMed ID: 1342987
[No Abstract] [Full Text] [Related]
3. [Current viewpoints in the anti-D prevention of rhesus alloimmunization in the pregnant woman and of hemolytic disease of the newborn infant (a review of the literature)].
Spasova K; Vŭlcheva B
Akush Ginekol (Sofiia); 1986; 25(3):84-90. PubMed ID: 3019168
[No Abstract] [Full Text] [Related]
4. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.
Kumpel BM
Transfusion; 2006 Sep; 46(9):1652-6. PubMed ID: 16965599
[No Abstract] [Full Text] [Related]
5. [Mechanism of action of anti-D-gamma globulin in preventing rhesus alloimmunization in the pregnant woman and hemolytic disease of the newborn infant].
Vŭlcheva B; Spasova K
Akush Ginekol (Sofiia); 1985; 24(2):73-6. PubMed ID: 2990248
[No Abstract] [Full Text] [Related]
6. Consensus conference on anti-D prophylaxis, April 7 & 8, 1997: final consensus statement. Royal College of Physicians of Edinburgh/Royal College of Obstetricians and Gynaecologists.
Urbaniak SJ
Transfusion; 1998 Jan; 38(1):97-9. PubMed ID: 9482402
[No Abstract] [Full Text] [Related]
7. [Prenatal immunoglobulin prevention in Rh(D)-negative nonsensitized pregnant women].
Katsulov A
Akush Ginekol (Sofiia); 1997; 36(2):1-2. PubMed ID: 9471891
[No Abstract] [Full Text] [Related]
8. Consensus Conference on Anti-D Prophylaxis. Edinburgh, United Kingdom, 8-9 April 1997. Papers and abstracts.
Br J Obstet Gynaecol; 1998 Nov; 105 Suppl 18():iv, 1-44. PubMed ID: 10328662
[No Abstract] [Full Text] [Related]
9. The history of rhesus prophylaxis with anti-D.
Wegmann A; Glück R
Eur J Pediatr; 1996 Oct; 155(10):835-8. PubMed ID: 8891551
[No Abstract] [Full Text] [Related]
10. RhD hemolytic disease of the newborn.
Bowman JM
N Engl J Med; 1998 Dec; 339(24):1775-7. PubMed ID: 9845715
[No Abstract] [Full Text] [Related]
11. The introduction of human monoclonal anti-D for therapeutic use.
Fletcher A; Thomson A
Transfus Med Rev; 1995 Oct; 9(4):314-26. PubMed ID: 8541714
[No Abstract] [Full Text] [Related]
12. Prevention of haemolytic disease of the newborn due to anti-D.
Tovey G; Wagstaff W
Br Med J (Clin Res Ed); 1981 Jul; 283(6284):142. PubMed ID: 6266575
[No Abstract] [Full Text] [Related]
13. Efforts should be made to eradicate Rh hemolytic disease of the fetus and newborn.
Caiola G
Obstet Gynecol Surv; 1984 Jan; 39(1):55-7. PubMed ID: 6320075
[No Abstract] [Full Text] [Related]
14. [Social Welfare Board's recommendations for preventive treatment in the origin of Rh immunization].
Högman C; Nilsson BA
Jordemodern; 1987 Oct; 100(10):321-4. PubMed ID: 2826372
[No Abstract] [Full Text] [Related]
15. Mechanisms of anti-D action in the prevention of hemolytic disease of the fetus and newborn.
Brinc D; Lazarus AH
Hematology Am Soc Hematol Educ Program; 2009; ():185-91. PubMed ID: 20008198
[TBL] [Abstract][Full Text] [Related]
16. [Prevention of fetomaternal anti-rhesus-D allo-immunization: methods used and topics discussed].
Carbonne B; Goffinet F; Marpeau L
J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S85-1S86. PubMed ID: 16495832
[No Abstract] [Full Text] [Related]
17. Clinical significance of anti-G.
Lenkiewicz B; Zupańska B
Transfus Med; 2002 Jun; 12(3):221. PubMed ID: 12071879
[No Abstract] [Full Text] [Related]
18. Rh-immunoglobulin: Rh prophylaxis.
Bowman J
Best Pract Res Clin Haematol; 2006; 19(1):27-34. PubMed ID: 16377539
[No Abstract] [Full Text] [Related]
19. The prevention of Rh haemolytic disease of the fetus and newborn--general background.
Contreras M
Br J Obstet Gynaecol; 1998 Nov; 105 Suppl 18():7-10. PubMed ID: 9863972
[No Abstract] [Full Text] [Related]
20. Economics of anti-rhesus prophylaxis in an African population.
Verkuyl DA
Cent Afr J Med; 1987 Feb; 33(2):32-7. PubMed ID: 3121186
[No Abstract] [Full Text] [Related]
[Next] [New Search]
